TMCnet News
49.0% Return Seen to Date on SmarTrend Cadence Pharmaceuticals Call (CADX)Jan 17, 2013 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Cadence Pharmaceuticals (NASDAQ:CADX) on November 26th, 2012 at $3.65. In approximately 2 months, Cadence Pharmaceuticals has returned 48.97% as of today's recent price of $5.43. In the past 52 weeks, shares of Cadence Pharmaceuticals have traded between a low of $2.56 and a high of $5.66 and are now at $5.43, which is 112% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.8% while the 200-day MA has risen 0.7%. Cadence Pharmaceuticals, Inc. is a biopharmaceutical company that develops drugs for use in hospitals. The Company produces intravenous APAP for the treatment of acute pain and fever, and omiganan for the prevention of intravascular catheter-related infections. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Cadence Pharmaceuticals shares.Log in and add Cadence Pharmaceuticals (CADX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |